Turnaround time
10 workdays
48.4
40
DNA test for the MYO5A deletion that causes lavender foal syndrome, also called LFS, in Arabian horses.
Overview
This genetic test examines the MYO5A deletion that causes lavender foal syndrome. The condition is also known as Lavender Foal Syndrome, LFS, coat colour dilution lethal and a neonatal neurological syndrome in Arabian horses.
LFS is a severe autosomal recessive disorder in newborn foals. Affected foals often have a distinctive diluted, silvery or lavender-like coat colour and severe neurological signs. Typical signs include inability to stand or nurse, opisthotonus, muscle spasms, seizure-like episodes and severe coordination problems. The condition is fatal.
LFS is inherited as an autosomal recessive disorder. A horse with one copy is a carrier. A foal with two copies develops LFS; this causes a fatal neurological disease shortly after birth.
Included subanalyses
This analysis includes the following subanalysis:
Allele combinations & result interpretations
Below, for each tested locus, you will find the possible allele combinations that may be reported within this analysis, together with a brief explanation of their genetic meaning. The interpretation of possible interactions between different loci is included in the report, but is not shown here in full because that would lead to too many combinations on this page. The final expression may also depend on other genes and their interaction.
Genotype / allele combination: Clear genotype (N/N)
The tested variant for LFS was not detected. This horse does not pass this specific variant to offspring.
Genotype / allele combination: Carrier (N/LFS)
This horse carries one copy of the variant for LFS. The animal is a carrier and can pass the variant on; when bred to another carrier, an affected foal can be produced.
Genotype / allele combination: Affected genotype (LFS/LFS)
This foal has two copies of the MYO5A LFS variant. This causes lavender foal syndrome: a fatal neurological disorder with a typical diluted coat colour and severe neurological signs shortly after birth.
Sampling and submission guidelines







References